Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.

@article{Haynes2007IntratympanicDF,
  title={Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.},
  author={David Haynes and M. J. O'Malley and Seth Cohen and Kenneth E Watford and Robert F. Labadie},
  journal={The Laryngoscope},
  year={2007},
  volume={117 1},
  pages={3-15}
}
OBJECTIVE Intratympanic steroids are increasingly used in the treatment of inner ear disorders, especially in patients with sudden sensorineural hearing loss (SNHL) who have failed systemic therapy. We reviewed our experience with intratympanic steroids in the treatment of patients with sudden SNHL to determine overall success, morbidity, and prognostic factors. HYPOTHESIS Intratympanic steroids have minimal morbidity and the potential to have a positive effect on hearing recovery in patients… CONTINUE READING